Home > Boards > Free Zone > Welcome to InvestorsHub > A Monster Energy Nascar Challenge

yes, science is great today, I have 3

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Seminole Red Member Profile
Member Level 
Followed By 167
Posts 123,665
Boards Moderated 3
Alias Born 07/02/05
160x600 placeholder
Mastercard on Track for Lowest Close in Over a Year -- Data Talk
Mastercard Incorporated Class A (MA) is currently at $313.17, down $9.84 or 3.05%
Shell's Deer Park Texas Refinery Sale Delayed, Reuters Reports
Activision on Track for Longest Losing Streak Since January 2014 -- Data Talk
Cumberland Pharmaceuticals Shares Double, Hit 52-Week High
STOXX Europe 600 Index Ends the Month 2.64% Lower at 462.96 -- Data Talk
FTSE 100 Index Ends the Month 2.46% Lower at 7059.45 -- Data Talk
DAX Ends the Month 3.75% Lower at 15100.13 -- Data Talk
CAC 40 Index Ends the Month 1.60% Lower at 6721.16 -- Data Talk
STOXX Europe 50 Index Ends the Month 2.57% Lower at 3593.42 -- Data Talk
EURO STOXX 50 Index Ends the Month 4.41% Lower at 4063.06 -- Data Talk
U.S. Crude-Oil Stockpiles Likely Decreased in DOE Data, Analysts Say
FTSE Closes Down as Omicron Variant Sparks Volatility
Cabot Properties Sells Logistics Portfolio to Blackstone for $2.8 Billion
Oersted Secures 12-Year Power Purchase Contract With Google
Array Technologies Shares Fall With Plans for Convertible Notes Offering
Top Company News of the Day
U.S. Ethanol Production and Stocks Estimates for Nov. 26
TG Therapeutics Shares Drop 38% After Plans for Advisory Meeting
Consumer Confidence Fell in November Amid Inflation Worries
Clarus Therapeutics Shares Rise 27% on New U.S. Patents
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
MEI Pharma Shares Rise 22% After Positive Data for Zandelisib Trial
TG Therapeutics Shares Drop 35% Premarket After FDA Plans for Advisory Meeting
Codiak BioSciences Gets FDA Approval for ExoASO-STAT6 IND Application
MTN Group to Cut Stake in MTN Nigeria Via Share Placing
AbbVie Submits Europe Application for Risankizumab for Crohn's Disease
Hepion Pharmaceuticals Gets Fast-Track Designation for NASH Treatment
NextEra to Sell 50% Stake in Renewables Portfolio to Ontario Teachers' Pension Plan
Right Time for New Leadership, Inditex Chairman Says, as Founder's Daughter Prepares to Take His Place -- Update
Stellantis, Daimler's Mercedes-Benz Invest in Battery Maker Factorial Energy
Seminole Red Member Level  Tuesday, 10/01/19 04:38:25 PM
Re: AUdad post# 150919
Post # of 158520 
yes, science is great today, I have 3 stents and back to good health....130/70bp 205 instead of 295....took me 3 years and it fells good to be active again

just another day

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences